Motus GI Holdings, Inc.
OTC: MOTS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mark Pomeranz
- Employees
- 15
- Headquarters
- Fort Lauderdale, United States
- IPO year
- 2018
- Market cap
- $639.0
- Website
- https://www.motusgi.com
Loading MOTS…
Loading profile data…Frequently asked questions about MOTS
What does Motus GI Holdings, Inc. (MOTS) do?
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. an...
Where does MOTS trade?
Motus GI Holdings, Inc. (MOTS) trades on the Other OTC.
What sector is MOTS in?
Motus GI Holdings, Inc. (MOTS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Motus GI Holdings, Inc.?
Mark Pomeranz is the chief executive officer of Motus GI Holdings, Inc. (MOTS).
Where is Motus GI Holdings, Inc. headquartered?
Motus GI Holdings, Inc. is headquartered in United States.
Does MOTS pay a dividend?
Motus GI Holdings, Inc. (MOTS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MOTS go public?
Motus GI Holdings, Inc. (MOTS) completed its initial public offering in 2018.